Asfotase

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 196 publications

Effects of comorbid chronic kidney disease on late-onset hypophosphatasia mice under treatment with asfotase alfa.

Effects of comorbid chronic kidney disease on late-onset hypophosphatasia mice under treatment with asfotase alfa.

Journal: JBMR plus
Published: December 18, 2025

Change in fracture rate and healthcare resource utilization among patients with hypophosphatasia following initiation of asfotase alfa: a retrospective US claims database analysis.

Change in fracture rate and healthcare resource utilization among patients with hypophosphatasia following initiation of asfotase alfa: a retrospective US claims database analysis.

Journal: JBMR plus
Published: October 09, 2025

Phenotype and genotype of hypophosphatasia cases in Saudi Arabia: multi-center case cohort.

Phenotype and genotype of hypophosphatasia cases in Saudi Arabia: multi-center case cohort.

Journal: Frontiers in genetics
Published: October 04, 2025

Hypophosphatasia-pathophysiological understanding, preclinical data looking beyond the skeleton, and upcoming treatments.

Hypophosphatasia-pathophysiological understanding, preclinical data looking beyond the skeleton, and upcoming treatments.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: August 14, 2025

Hypophosphatasia in Neonatal Twins With Generalized Skeletal Hypomineralisation.

Hypophosphatasia in Neonatal Twins With Generalized Skeletal Hypomineralisation.

Journal: Journal of paediatrics and child health
Published: July 30, 2025

Atypical Fracture From Bisphosphonate Use in Hypophosphatasia With Improved Bone Response to Teriparatide Therapy.

Atypical Fracture From Bisphosphonate Use in Hypophosphatasia With Improved Bone Response to Teriparatide Therapy.

Journal: JCEM case reports
Published: July 28, 2025

Lentivirus-based HPSC therapy provides effective and long-term treatment in hypophosphatasia mouse model.

Lentivirus-based HPSC therapy provides effective and long-term treatment in hypophosphatasia mouse model.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 21, 2025

Targeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X-Linked Hypophosphatemia in Mice.

Targeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X-Linked Hypophosphatemia in Mice.

Journal: Journal of periodontal research
Published: June 20, 2025

ENPP1 inhibition as a therapeutic approach for later-onset hypophosphatasia.

ENPP1 inhibition as a therapeutic approach for later-onset hypophosphatasia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 28, 2025

ENPP1 inhibition as a therapeutic approach for later-onset hypophosphatasia.

ENPP1 inhibition as a therapeutic approach for later-onset hypophosphatasia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 28, 2025

Hypophosphatasia in childhood: Diagnosis to management.

Hypophosphatasia in childhood: Diagnosis to management.

Journal: Osteoporosis and sarcopenia
Published: April 25, 2025

Hypophosphatasia in children: From low alkaline phosphatase activity to diagnosis, genetic testing, and treatment options. A narrative review.

Hypophosphatasia in children: From low alkaline phosphatase activity to diagnosis, genetic testing, and treatment options. A narrative review.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: April 15, 2025
Showing 1-12 of 196

Last Updated: 06/30/2026